In Europe, cancer of the pancreas is the 10th most frequent cancer, accounting for some 2.6% of cancer in both sexes, and the eighth leading cause of cancer-related death with ∼65 000 deaths each year. In men, the annual incidence rates ranged between 8.7 (East) and 7.3 (North and West) per 100 000, while in women between 5.7 (North) and 4.5 (East). Men have an approximately one-half greater age-adjusted incidence rate than women. Incidence increases steeply with age from 1.5 per 100 000/year in patients 15–44 years old to 55 per 100 000/year in patients >65 years of age. Pancreatic cancer is one of the most highly fatal cancers, with >95% of those affected dying of their disease.
Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up / Cascinu, Stefano; S., Jelic; E. S., M.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 20 Suppl 4:(2009), pp. 37-40.
Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
CASCINU, Stefano;
2009-01-01
Abstract
In Europe, cancer of the pancreas is the 10th most frequent cancer, accounting for some 2.6% of cancer in both sexes, and the eighth leading cause of cancer-related death with ∼65 000 deaths each year. In men, the annual incidence rates ranged between 8.7 (East) and 7.3 (North and West) per 100 000, while in women between 5.7 (North) and 4.5 (East). Men have an approximately one-half greater age-adjusted incidence rate than women. Incidence increases steeply with age from 1.5 per 100 000/year in patients 15–44 years old to 55 per 100 000/year in patients >65 years of age. Pancreatic cancer is one of the most highly fatal cancers, with >95% of those affected dying of their disease.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
